NEO Clinic Tokyo
Pioneering Cancer Immunotherapy

Traditionally, surgery, chemotherapy, and radiation therapy have constituted the foundation of cancer treatment. However, these conventional approaches are imperfect, given that half of all cancer patients experience recurrence or progression, leading to unfavorable outcomes.

The solution lies in cancer immunotherapy. With a 20-year legacy of groundbreaking research, NEO Clinic Tokyo employs an innovative treatment model, harnessing the body’s immune system to eliminate cancer cells. Central to its efficacy is genomic analysis, specifically whole-genome or whole-exome sequencing of cancer and normal cells. This process identifies neoantigens— distinct markers exclusive to cancer cells—and pioneers specialized treatment known as neoantigen peptide vaccines. Operating like coronavirus vaccines, these vaccines prompt the patient’s T cells to recognize and attack cancer cells expressing the identified neoantigens. The immune response spares normal cells, resulting in minimal to no serious side effects.

Understanding cancer’s complexity, the clinic explores synergistic effects by combining neoantigen vaccines with immune checkpoint inhibitors, anti-VEGF antibodies, multikinase inhibitors, and traditional chemotherapy and radiation therapy. The clinic also provides molecularly targeted drugs based on genomic analysis. This holistic approach shows promising outcomes, such as better survival rates and a higher quality of life.

NEO Clinic Tokyo’s success stories showcase instances where patients, initially given a dire prognosis by other healthcare providers, not only surpassed expectations but also enjoyed an extended and healthy life. Through innovative therapies, NEO Clinic Tokyo challenges conventional timelines associated with cancer survival rates.

Emphasizing disease prevention, NEO Clinic Tokyo pioneers senolytic therapy, with off-label agents use and mesenchymal stem cells-derived exosomes and cytokines being one of its notable contributions. The senolytic therapy reflects the clinic’s dedication to comprehensive healthcare. Furthermore, the clinic predicts future diseases through genomic analysis and provides personalized preventive medicine.

What sets NEO Clinic Tokyo apart is its commitment to providing ‘plus alpha’ support, elevating standard cancer therapies with additional personalized elements. This synergistic approach combines standard therapies with supplementary support, creating a more holistic and effective treatment paradigm.

Moreover, NEO Clinic Tokyo has become a refuge for those dissatisfied with larger hospitals. Patients turned away from major medical institutions witnessed a notably higher survival rate at NEO Clinic Tokyo. This shift in outcomes highlights the clinic’s dedication to offering a personalized touch and support beyond standard protocols.

We distinguish ourselves by offering the latest developments in cancer medicine. Our services also cater to individuals who have either discontinued therapy or are seeking to initiate a therapy journey

“We distinguish ourselves by offering the latest developments in cancer medicine. Our services cater to individuals who have either discontinued therapy or are seeking to initiate a therapy journey,” says Yasuki Hijikata, medical doctor, doctor of philosophy at NEO Clinic Tokyo.

NEO Clinic Tokyo’s emphasis on high survival rates is underscored by their availability for consultations and support. Collaborating with prestigious institutions like Research Hospital, The Institute of Medical Science, The University of Tokyo and Maeda hospital enriches its knowledge base.

At the heart of NEO Clinic Tokyo’s approach is a commitment to using the latest medicines, with a dual focus on patients who have paused therapy and those seeking to embark on a therapeutic journey. Patients worldwide are encouraged to reach out, making the clinic a global hub for advanced cancer care.

NEO Clinic Tokyo’s continued advancements in the field show that its journey is not just about treating cancer; it’s about transforming lives and instilling hope in the face of adversity.